Revised international surveillance case definition of transfusion-associated circulatory overload: a classification agreement validation study

The Lancet Haematology

Volumn 6, Issue 7, 2019, Pages e350-e358

  Wiersum Osselton, Johanna C ^a   Whitaker, Barbee ^b   Grey, Sharran ^c,d   Land, Kevin ^e   Perez, Gabriela ^f   Rajbhandary, Srijana ^f   Andrzejewski, Chester ^g   Bolton Maggs, Paula ^d   Lucero, Harriet ^h   Renaudier, Philippe ⁱ   Robillard, Pierre ^j   Santos, Matilde ^k   Schipperus, Martin ^a,l  

^a TRIP   (Netherlands)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c BOLTON NHS FOUNDATION TRUST   (United Kingdom)

^d Serious Hazards of Transfusion   (United Kingdom)

^e Vitalant   (United States)

^f AABB   (United States)

^g University of Massachusetts Medical School   (United States)

^h CHRISTIE HOSPITAL   (United Kingdom)

ⁱ CENTRE HOSPITALIER UNIVERSITAIRE DE FORT DE FRANCE   (France)

^j HÉMA QUÉBEC   (Canada)

^k IP   (Portugal)

^l HAGA HOSPITAL   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; ARTERIAL PRESSURE; ARTERY DILATATION; ARTICLE; AWARENESS; BLOOD DONOR; BLOOD SAFETY; BLOOD TRANSFUSION; CYANOSIS; DISEASE SEVERITY; DISEASE SURVEILLANCE; DIURESIS; DYSPNEA; FLUID BALANCE; HUMAN; HYPERTENSION; HYPERVOLEMIA; HYPOTENSION; HYPOXIA; LUNG AUSCULTATION; LUNG EDEMA; MORBIDITY; MORTALITY; NONCARDIOGENIC LUNG EDEMA; OXYGEN SATURATION; PNEUMONIA; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; TACHYCARDIA; TACHYPNEA; THORAX RADIOGRAPHY; TRANSFUSION ASSOCIATED CIRCULATORY OVERLOAD; VALIDATION STUDY; WHEEZING; BLOOD TRANSFUSION REACTION; CLASSIFICATION; HEALTH CARE ORGANIZATION;

BLOOD SAFETY; BLOOD TRANSFUSION; HUMANS; RISK FACTORS; SOCIETIES, SCIENTIFIC; SURVEYS AND QUESTIONNAIRES; TRANSFUSION REACTION;

EID: 85067701237     PISSN: None     EISSN: 23523026     Source Type: Journal    
DOI: 10.1016/S2352-3026(19)30080-8     Document Type: Article

References (30)

1. Bolton-Maggs, P, Poles, D, Bellamy, M, et al. The 2017 annual SHOT report. https://www.shotuk.org/wp-content/uploads/myimages/SHOT-Report-2017-WEB-Final-v4-25-9-18.pdf, 2018. (Accessed 14 March 2019)
2. Bolton-Maggs, P, Poles, D, Watt, A, et al. The 2013 annual SHOT report. https://www.shotuk.org/wp-content/uploads/myimages/2013.pdf, 2014. (Accessed 14 March 2019)
3. Transfusion and Transplantation Reactions in Patients. TRIP report 2017, extended version: hemovigilance. https://www.tripnet.nl/wp-content/uploads/2018/11/Trip.HEMO_uitgebreid_def-2017-met-links.pdf, 2018. (Accessed 14 March 2019)
4. US Food and Drug Administration. Fatalities reported to FDA following blood collection and transfusion. Annual summary for fiscal year 2016. https://www.fda.gov/downloads/BiologicsBloodVaccines/SafetyAvailability/ReportaProblem/TransfusionDonationFatalities/UCM598243.pdf. (Accessed 14 March 2019)
5. National Haemovigilance Office. NHO Report 2008/2009. https://www.giveblood.ie/Clinical-Services/Haemovigilance/Publications/NHO_Report_2008_2009.pdf. (Accessed 14 March 2019)
6. Public Health Agency of Canada. Transfusion transmitted injuries surveillance system (TTISS): 2009–2013 summary results. https://www.canada.ca/content/dam/hc-sc/healthy-canadians/migration/publications/drugs-products-medicaments-produits/blood-transfusion-2013-transfusionnels/alt/transfusion-eng.pdf. (Accessed 14 March 2019)
7. Agence Nationale de Sécurité du Médicament et des Produits de Santé. Rapport d'activité hémovigilance. https://ansm.sante.fr/var/ansm_site/storage/original/application/eb4a3a3c16eecfdd5743fe0931100a01.pdf, 2016. (Accessed 14 March 2019)
8. Roubinian, NH, Hendrickson, JE, Triulzi, DJ, et al. Incidence and clinical characteristics of transfusion-associated circulatory overload using an active surveillance algorithm. Vox Sang 112 (2017), 56–63.
9. Clifford, L, Singh, A, Wilson, GA, et al. Electronic health record surveillance algorithms facilitate the detection of transfusion-related pulmonary complications. Transfusion 53 (2013), 1205–1216.
10. Andrzejewski, C Jr, Casey, MA, Popovsky, MA, How we view and approach transfusion-associated circulatory overload: pathogenesis, diagnosis, management, mitigation, and prevention. Transfusion 53 (2013), 3037–3047.
11. Lieberman, L, Maskens, C, Cserti-Gazdewich, C, et al. A retrospective review of patient factors, transfusion practices, and outcomes in patients with transfusion-associated circulatory overload. Transfusion Med Rev 27 (2013), 206–212.
12. Alam, A, Lin, Y, Lima, A, Hansen, M, Callum, JL, The prevention of transfusion-associated circulatory overload. Transfusion Med Rev 27 (2013), 105–112.
13. Popovsky, M, Robillard, P, Schipperus, M, Stainsby, D, Tissot, J-D, Wiersum-Osselton, J, Proposed standard definitions for surveillance of non infectious adverse transfusion reactions. International Society of Blood Transfusion. http://www.isbtweb.org/fileadmin/user_upload/Proposed_definitions_2011_surveillance_non_infectious_adverse_reactions_haemovigilance_incl_TRALI_correction_2013.pdf, 2013. (Accessed 14 March 2019)
14. Bolton-Maggs, P, Poles, D, Thomas, D, et al. The 2012 annual SHOT report. https://www.shotuk.org/wp-content/uploads/myimages/SHOT-Annual-Report-20121.pdf, 2013. (Accessed 14 March 2019)
15. Popovsky, M, Robillard, P, Schipperus, M, Stainsby, D, Tissot, J-D, Wiersum-Osselton, J, Definitions and tools for haemovigilance. International Society of Blood Transfusion. http://www.isbtweb.org/fileadmin/user_upload/files-2015/haemovigilance/definitions/Definitions%20and%20tools%20process%202013%20for%20haemovigilance.pdf, 2013. (Accessed 14 March 2019)
16. Bolton-Maggs, P, Poles, D, Thomas, D, et al. The 2014 annual SHOT report. https://www.shotuk.org/wp-content/uploads/myimages/report-2014.pdf, 2015. (Accessed 14 March 2019)
17. Bolton-Maggs, P, Poles, D, Thomas, D, et al. The 2015 annual SHOT report. https://www.shotuk.org/wp-content/uploads/myimages/SHOT-2015-Annual-Report-Web-Edition-Final-bookmarked-1.pdf, 2016. (Accessed 14 March 2019)
18. Wiersum-Osselton, JC, Whitaker, B, Grey, S, et al. Validation protocol synopsis. Definitions for use in validation phase 2, autumn 2017. http://www.isbtweb.org/fileadmin/user_upload/TACO_draft_TRALI_TAD_combined_4.docx. (Accessed 14 March 2019)
19. Harvey, AR, Basavaraju, SV, Chung, KW, Kuehnert, MJ, Transfusion-related adverse reactions reported to the National Healthcare Safety Network Hemovigilance Module, United States, 2010 to 2012. Transfusion 55 (2015), 709–718.
20. Politis, C, Wiersum, JC, Richardson, C, et al. The International Haemovigilance Network database for the surveillance of adverse reactions and events in donors and recipients of blood components: technical issues and results. Vox Sang 111 (2016), 409–417.
21. Parmar, N, Pendergrast, J, Lieberman, L, Lin, Y, Callum, J, Cserti-Gazdewich, C, The association of fever with transfusion-associated circulatory overload. Vox Sang 112 (2017), 70–78.
22. Andrzejewski, C Jr, Popovsky, MA, Stec, TC, et al. Hemotherapy bedside biovigilance involving vital sign values and characteristics of patients with suspected transfusion reactions associated with fluid challenges: can some cases of transfusion-associated circulatory overload have proinflammatory aspects?. Transfusion 52 (2012), 2310–2320.
23. Les incidents et accidents transfusionnels signalés au système d'hémovigilance du Québec en 2007. http://publications.msss.gouv.qc.ca/msss/fichiers/2010/rapport-2007-sang.pdf, 2010. (Accessed 14 March 2019)
24. Transfusion and Transplantation Reactions in Patients. TRIP annual report 2014, extended version: Hemovigilance. https://www.tripnet.nl/pages/en/documents/TRIP2014Hemovigilancedefinitief.pdf. (Accessed 14 March 2019)
25. Popovsky, MA, Audet, AM, Andrzejewski, C Jr, Transfusion-associated circulatory overload in orthopedic patients: a multi-institutional study. Immunohematology 12 (1996), 87–89.
26. Knowles, S, Cohen, H, Poles, D, et al. The 2010 annual SHOT report. https://www.shotuk.org/wp-content/uploads/myimages/2011/07/SHOT-2010-Report1.pdf, 2011. (Accessed 14 March 2019)
27. Vlaar, APJ, Toy, P, Fung, M, et al. A consensus redefinition of transfusion-related acute lung injury. Transfusion, 2019 published online April 16. DOI:10.1111/trf.15311.
28. Zhou, L, Giacherio, D, Cooling, L, Davenport, RD, Use of B-natriuretic peptide as a diagnostic marker in the differential diagnosis of transfusion-associated circulatory overload. Transfusion 45 (2005), 1056–1063.
29. Klanderman, RB, Bosboom, JJ, Migdady, Y, et al. Transfusion-associated circulatory overload—a systematic review of diagnostic biomarkers. Transfusion 59 (2019), 795–805.
30. Haass K. TACO, TRALI, and TAD reactions reported to the NHSN Hemovigilance Module. State of the Research Symposium on TACO, TRALI, and TAD; Boston, MA; Oct 12, 2018.